Results 61 to 70 of about 18,040 (170)

Burden of rotavirus in India - Is rotavirus vaccine an answer to it?

open access: yesIndian Journal of Public Health, 2012
Rotavirus is currently by far the most common cause of severe diarrhea in infants and young children worldwide and of diarrheal deaths in developing countries.
Davendra K Taneja, Akash Malik
doaj   +1 more source

Diversity Patterns of Domestic Herbivore Viruses in China Reveal Transmission Dynamics with Disease Management Implications

open access: yesAdvanced Science, Volume 13, Issue 32, 9 June 2026.
This study performs pan‐viromic profiling of 14,529 samples from 5,710 domestic herbivores across five Chinese provinces, establishing the DhCN‐Virome (1,085,360 viral metagenomes). It reveals species/sample‐specific viromic signatures and cross‐species transmission dynamics, aiding unified disease control.
Yue Sun   +19 more
wiley   +1 more source

Human rotavirus infection. Strategies for the vaccinal prevention

open access: yesВопросы вирусологии, 2016
Rotavirus was first isolated in 1973 in Australia from children with diarrhea. Hundreds of thousands of children die annually in developing countries from this virus with the mortality peaks in the most impoverished among them.
K. P. Alekseev   +3 more
doaj   +1 more source

Human rotavirus vaccine

open access: yesUirusu, 2012
Since the presentation of the clinical trial reports showing the excellent efficacy and safety of the two human rotavirus vaccines (Rotarix and RotaTeq), the human rotavirus vaccines have received worldwide attention. The two vaccines have been approved in more than 100 countries, and were included in routine immunization schedule in about 30 countries.
openaire   +3 more sources

Assessing the Impact of Rotavirus Vaccination in Iranian Children Under Five: An Agent‐Based Modelling Approach

open access: yesHealth Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Rotavirus is a leading cause of severe diarrhoeal disease in young children worldwide. In 2024, Iran introduced the pentavalent oral vaccine Rotasiil® into its national immunization program. This study aimed to estimate its potential epidemiological impact using an agent‐based modeling (ABM) approach.
Amirhesam Moosazadeh   +2 more
wiley   +1 more source

Rotavirus in developing countries: molecular diversity, epidemiological insights, and strategies for effective vaccination

open access: yesFrontiers in Microbiology
Rotavirus (RV) causes the loss of numerous children’s lives worldwide each year, and this burden is particularly heavy in low- and lower-middle-income countries where access to healthcare is limited. RV epidemiology exhibits a diverse range of genotypes,
Asma Sadiq, Jadoon Khan
doaj   +1 more source

Vaccine Safety and Efficacy in Preventing Rotavirus Infection

open access: yesБиопрепараты: Профилактика, диагностика, лечение, 2019
The rotavirus infection causes acute gastroenteritis and is a major cause of lethal severe dehydrating diarrhoea in children under 5 years of age worldwide.
V. A. Shevtsov   +5 more
doaj   +1 more source

Rotavirus vaccines and vaccination in Latin America [PDF]

open access: yesRevista Panamericana de Salud Pública, 2000
Worldwide, rotaviruses account for more than 125 million cases of infantile gastroenteritis and nearly 1 million deaths per year, mainly in developing countries. Rather than other control measures, vaccination is most likely to have a major impact on rotavirus disease incidence. The peak incidence of rotavirus diarrhea occurs between 6 and 24 months of
A C, Linhares, J S, Bresee
openaire   +2 more sources

A Protocol of National Mixed‐Methods Assessment of Childhood and Maternal Immunization

open access: yesHealth Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Accurate measurement of routine immunization coverage is essential for detecting immunity gaps, guiding programmatic responses, and supporting equitable vaccine delivery. Iran's Expanded Programme on Immunization has achieved high coverage, but administrative estimates can mask some disparities.
Seyed Aria Nejadghaderi   +8 more
wiley   +1 more source

Efficacy and Safety of Messenger RNA Vaccines

open access: yesHealth Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims The rapid development of mRNA vaccines has revolutionized infectious disease prevention and cancer immunotherapy. While their efficacy is well established, concerns about safety and immunopathological risks persist. This study aims to evaluate the immunogenicity, safety profiles, and design considerations of mRNA vaccines ...
Kesaobaka Batisani, David Chisompola
wiley   +1 more source

Home - About - Disclaimer - Privacy